Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Becton Dickinson (NY: BDX )

250.13 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EST, Jan 30, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 250.13
Bid (Size) 235.00 (1)
Ask (Size) 260.25 (7)
Prev. Close 250.13
Today's Range 250.13 - 250.13
52wk Range 215.90 - 280.62
Shares Outstanding 287,190,180
Dividend Yield 1.33%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
A Bullish Sign Appears On Becton, Dickinson's Chart
 
Via Benzinga
Sharps Technology Is Commercializing The Future Of Specialty Syringe Systems For The Healthcare Industry Through Its Next-Gen Polymer-Based Products
By David Willey, Benzinga 
Via TheNewswire.com
Topics Economy
Exposures Supply Chain

Performance

YTD
-2.36%
-2.36%
1 Month
-2.36%
-2.36%
3 Month
+6.00%
+6.00%
6 Month
+2.19%
+2.19%
1 Year
-1.58%
-1.58%

More News

Read More
Sharps Technology Is Commercializing The Future Of Specialty Syringe Systems For The Healthcare Industry Through Its Next-Gen Polymer-Based Products
Via News Direct
Topics Economy
Exposures Supply Chain
Sharps Technology Is Commercializing The Future Of Specialty Syringe Systems For The Healthcare Industry Through Its Next-Gen Polymer-Based Products
Via Benzinga
Becton Dickinson, Freeport-McMoRan, GXO Logistics And This Mid-Cap ETF On CNBC's 'Final Trades'
Via Benzinga
What 6 Analyst Ratings Have To Say About Becton, Dickinson
Via Benzinga
2 Medical Stocks to Watch Heading Into 2023
Via The Motley Fool
Global Drug Delivery Systems Market Size Projected to Reach $71.75 Billion By 2029
Via FinancialNewsMedia
Exposures COVID-19
Sharps Technology Is Injecting A Better Solution Into The Healthcare Syringe Industry
Via Benzinga
2 Relatively Safe Dividend Stocks to Buy Today and Hold Forever
Via The Motley Fool
Embecta Stock Tumbles On Mixed Q4 Results, Softer Guidance
Via Benzinga
What 4 Analyst Ratings Have To Say About Becton, Dickinson
Via Benzinga
2 Top Dividend Kings to Buy for the Long Haul
Via The Motley Fool
Reliable Passive Income: an Analysis on Dividend Kings
Via The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 12, 2022
Via Benzinga
NIO To $34? Plus This Analyst Sees $245 For Becton, Dickinson and Company
Via Benzinga
$1000 Invested In This Stock 20 Years Ago Would Be Worth $7,700 Today
Via Benzinga
Becton Dickinson's FY23 Guidance Trails Wall Street View Reflecting Foreign Currency Impact
Via Benzinga
Edwards Life Sciences Stock Disaster Could Be Your Bounty
Via MarketBeat
Topics Death
Exposures COVID-19 Death
Got $5,000? Buy These 3 Dividend Kings And Hold Them Forever
Via The Motley Fool
Intuitive Surgical Stock is Both a Legacy and Next-Gen Play
Via MarketBeat
Topics Economy
Exposures COVID-19 Interest Rates Supply Chain
BD, BIOCORP Sign Agreement to Bring Connectivity, Traceability to Self-Administered Injectable Drugs
From BIOCORP
Via Business Wire
Becton Dickinson To Rally 23%? This Analyst Predicts $210 For NVIDIA
Via Benzinga
What 4 Analyst Ratings Have To Say About Becton, Dickinson
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.